Nolato AB (publ) (LON:0OA9)

London flag London · Delayed Price · Currency is GBP · Price in SEK
62.15
-0.45 (-0.72%)
At close: Feb 21, 2025
41.25%
Market Cap 1.25B
Revenue (ttm) 697.49M
Net Income (ttm) 47.49M
Shares Out n/a
EPS (ttm) 0.18
PE Ratio 26.22
Forward PE n/a
Dividend 0.11 (0.17%)
Ex-Dividend Date May 7, 2025
Volume 1,206
Average Volume 3,258
Open 62.70
Previous Close 62.60
Day's Range 62.15 - 63.00
52-Week Range 3.03 - 4.52
Beta 0.94
RSI 61.59
Earnings Date Feb 7, 2025

About Nolato AB

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products for medical technology, pharmaceutical, consumer electronics, telecom, automotive, hygiene, and other industrial sectors in Sweden, Other Nordic countries, Asia, Rest of Europe, and North America, and internationally. The company offers consumables and reusable labware for clinical, chemical, forensic, research, and industrial testing laboratories; develops and supports injection molding and assembly of products; laboratory products, inclu... [Read more]

Industry Miscellaneous Plastics Products
Founded 1938
Employees 5,837
Stock Exchange London Stock Exchange
Ticker Symbol 0OA9
Full Company Profile

Financial Performance

In 2024, Nolato AB's revenue was 9.66 billion, an increase of 1.24% compared to the previous year's 9.55 billion. Earnings were 658.00 million, an increase of 51.26%.

Financial numbers in SEK Financial Statements

News

Nolato AB (STU:NBF) Q4 2024 Earnings Call Highlights: Strong Profit Growth Amid Sector Challenges

Nolato AB (STU:NBF) Q4 2024 Earnings Call Highlights: Strong Profit Growth Amid Sector Challenges

15 days ago - GuruFocus

Q4 2024 Nolato AB Earnings Call Transcript

Q4 2024 Nolato AB Earnings Call Transcript

15 days ago - GuruFocus

Cyclical Industrials' Turnaround Is Close, Though Nolato Isn't Cheap, It's Still A Buy

Nolato is a Swedish polymer business with a focus on medical, integrated, and industrial solutions. The company's net cash position insulates it from debt risks, but it faces cyclicality risks in some...

1 year ago - Seeking Alpha